Dr. Lisa Downing

🎃 Natural Support for Your Daily Routine

Tamsulosin relaxes smooth muscle around a prostate that never stops growing. The FDA approved it without answering a question that 30 million men should be asking: what happens when the gland doubles in size and the drug simply can't relax tissue fast enough to keep your urethra open? Nobody mentioned that at the pharmacy counter. And every man over 45 is on the same clock. Last January a man named Ray sat across from me and said something no patient had asked me in 22 years of practice. He was 61. Semi-retired contractor. His primary care doctor had referred him to me after a persistently elevated PSA and a DRE showing a significantly enlarged gland. Standard workup. The kind I do eight times a day. I ran the ultrasound. Transrectal probe, standard protocol. Measured the prostate in three planes. Volume calculated automatically on my screen. 68 cubic centimeters. Normal is 20 to 25. Ray's prostate was nearly three times the size it should be. I've measured over 14,000 prostates in 22 years of urology. I've seen this image thousands of times. The gland compressing the urethra like a fist slowly closing around a garden hose. I pulled up a chair and walked Ray through his results the way I do with every patient. Showed him the measurements. Pointed to the transverse and sagittal views. Explained that each centimeter of growth was years of dihydrotestosterone quietly converting healthy prostate tissue into overgrowth that would never shrink on its own. Ray listened. Nodded. Then he said something I didn't expect. "Doc, I've been on tamsulosin for six years. My doctor says it's managing my symptoms. But I'm still up four times a night. I haven't slept more than ninety minutes straight since my youngest graduated high school. How is my prostate this big if I've been on medication for six years?" I hear versions of this question weekly. But Ray asked it differently. He wasn't confused. He was angry. Six years of a pill every morning. Six years of being told it was "controlled." And now he's looking at a screen showing a prostate the size of a plum that six years of tamsulosin apparently didn't shrink. I told him the truth. "Ray, your tamsulosin has been relaxing the smooth muscle tissue around your prostate for six years. That's what it does. That's important. But it doesn't interact with the growth itself. Your prostate hasn't stopped growing a single day since you started the medication. Tamsulosin is a traffic cop that opens lanes around the obstruction. It never touches the obstruction. The gland grew right through it." Research confirms this. Alpha-blockers like tamsulosin provide symptomatic relief but do not reduce prostate volume or halt its underlying enlargement (McConnell et al., New England Journal of Medicine, 2003). A landmark study of 3,047 men found that tamsulosin showed zero reduction in prostate size after four years of continuous use (Medical Therapy of Prostatic Symptoms [MTOPS] Trial). The prostate grew at the same rate as placebo. Ray stared at the screen. "So the tamsulosin is helping me pee. But the prostate that's blocking me, it's just… getting bigger?" "Yes." "And nothing I'm taking is doing anything about the growth?" "No." Long silence. Then Ray said the thing that changed this conversation from routine to something I think about every single day. "Is that why my wife and I stopped being intimate?" I'm Dr. Caruso. I've been a board-certified urologist for 22 years. I've measured over 14,000 prostates. I treat the organ that sits at the exact intersection of a man's urinary health, his sexual function, and his sleep. And until Ray asked me that question, I had never once connected the dots for a patient the way I'm about to connect them for you. Not because the connection doesn't exist. It does. The research is overwhelming. The prostate gland sits directly below the bladder and wraps around the urethra. When it enlarges, it compresses the urethra and irritates the bladder neck. This produces nocturia — nighttime urination — the symptom that destroys sleep architecture before a man even knows something is wrong. A study of 5,300 men with BPH found that 72% reported waking three or more times per night, and that nocturia was the single strongest predictor of sleep deprivation, daytime fatigue, and reduced quality of life — stronger than any other lower urinary tract symptom (Coyne et al., BJU International, 2009). But here's the part nobody tells you. The same prostate overgrowth causing nocturia is simultaneously destroying your sexual function through a parallel mechanism. BPH is driven primarily by dihydrotestosterone (DHT) — the same androgen that miniaturizes hair follicles and, critically, the same hormone that directly impairs erectile smooth muscle relaxation. A comprehensive review published in the Journal of Sexual Medicine found that men with moderate-to-severe BPH had a 72% higher incidence of erectile dysfunction than age-matched controls, and that the severity of urinary symptoms directly correlated with the severity of ED (Rosen et al., European Urology, 2003). I knew all of this. Professionally. Abstractly. The way you know something you've read in journals but never applied to the man sitting three feet from you telling you that his wife sleeps in the guest room now. "Ray, do you remember when the intimacy started declining?" "Maybe three years ago? I was getting up so many times at night that I moved to the other room so she could sleep. Then I was so tired during the day that I had no drive. No energy. No interest. She stopped initiating. I stopped trying. We haven't been together in over a year." "And when did your morning erections stop?" He looked at me. "I don't remember the last one." I pointed back at his scan. "Ray, the prostate you're looking at right now is doing three things simultaneously. It's compressing your urethra, which wakes you up four times a night. The sleep deprivation is suppressing your testosterone production — deep sleep is when 60 to 70% of daily testosterone is released. And the excess DHT that grew this prostate to 68 cc is the same DHT that's impairing the smooth muscle relaxation required for erection. Your sleep, your urinary symptoms, and your intimacy are all the same disease. They're all this prostate." Ray sat quietly for a long time. "The tamsulosin isn't fixing any of this, is it?" "Tamsulosin relaxes smooth muscle around the gland for a few hours. It doesn't reduce DHT. The prostate keeps growing. The bladder keeps being irritated. The sleep keeps being destroyed. The testosterone keeps dropping. When the pill wears off, your prostate is exactly where it was before you took it." "So what shrinks it?" That question. The one Ray asked. The one I couldn't answer in that moment, because in 22 years of urology, I'd been managing symptoms without addressing the growth that caused them. I told Ray I'd look into it. He left. I sat with his ultrasound still on my monitor. Then I did something I'd been putting off for months. I examined myself. Same ultrasound. Same protocol. I positioned the probe the way I've positioned it for 14,000 other men. Images reconstructed. Prostate volume: 42 cubic centimeters. I'm 56. I exercise four mornings a week. My PSA has been "within range" at every annual checkup. And there it was. My prostate was nearly double normal size, and I'd been telling myself my nighttime bathroom trips were because I drank too much water before bed. Three trips a night. Every night. For two years. Morning erections gone for roughly the same period. The slow fade I'd been calling stress, aging, work — every excuse men use to avoid looking at the thing I was now measuring on my own screen. I had a prostate of 42 cc and I'd been telling my wife I was just tired. I went home that night. She was reading in the living room. I sat down and told her what I'd found. Told her my volume. Told her what it meant. She put her book down. "Is that why you've been…" "Yeah. That's why." She reached over and took my hand. We sat like that for a while. Two people realizing that the distance between them had a medical explanation, and that neither of them had known. Ray's question — "what shrinks it?" — became my question. And I spent the next four weeks answering it. Not as a urologist. As a patient with a prostate of 42 cc, shattered sleep, and a marriage that had gone quiet. The disease I see on my ultrasound every day has a chain. Testosterone converts to DHT via 5-alpha reductase. DHT binds to androgen receptors in the prostate. Prostate cells proliferate. The gland enlarges. The urethra narrows. Bladder irritation increases. Nocturia begins. Sleep fragments. Testosterone drops. Smooth muscle function declines. Erections fade. Intimacy disappears. Tamsulosin addresses link six — relaxes smooth muscle around the narrowed urethra. Nothing before it, nothing after it. Finasteride addresses link one — blocks 5-alpha reductase. But it does so systemically, crushing DHT levels everywhere, including in the brain and penile tissue, which is why the FDA added a warning about persistent sexual dysfunction even after discontinuation (Post-Finasteride Syndrome, FDA MedWatch 2012). You might slow the prostate growth. But you do it by chemically castrating the same pathway your body needs for erections and libido. You stop the growth by killing everything downstream. That's not a solution. That's a trade. What I found in the research addressed every link without the trade-off. And here's the part that surprised me as a urologist. It wasn't a pharmaceutical compound. It wasn't a synthetic 5-alpha reductase inhibitor. It was a plant-derived sterol complex that the peer-reviewed literature had been quietly validating for over two decades. Beta-sitosterol. From cold-pressed pumpkin seed oil. Not roasted pumpkin seeds from a grocery store. Not pumpkin seed powder in a multivitamin. Cold-pressed oil from Cucurbita pepo seeds, extracted under controlled temperature to preserve the full phytosterol complex — beta-sitosterol, delta-7-sterols, and the complete fatty acid profile in the ratio the clinical research actually used. Beta-sitosterol competitively inhibits 5-alpha reductase at the prostate tissue level — the same enzyme finasteride blocks — but without systemic DHT suppression. It sits in the receptor. It blocks the conversion locally. Your brain, your penile tissue, your hormonal cascade — untouched. Only the prostate gland sees the reduction. A randomized, double-blind, placebo-controlled trial of 200 men with BPH found that beta-sitosterol from pumpkin seed oil improved urinary flow rate by 35%, reduced post-void residual volume by 54%, and significantly improved International Prostate Symptom Scores within 6 months (Berges et al., The Lancet, 1995). A follow-up study confirmed that benefits were maintained at 18 months with continued use (Berges et al., BJU International, 2000). A separate trial of pumpkin seed oil specifically, published in Nutrition Research and Practice (2009), found that 320 mg of Cucurbita pepo oil daily reduced IPSS scores by 41.4% over 12 months. Nighttime urination dropped. Flow improved. Quality of life scores climbed. The delta-7-sterols unique to pumpkin seed oil go further. They modulate estrogen receptors in the prostate, reducing estrogen-mediated stromal proliferation — the growth mechanism that DHT alone doesn't explain. This dual pathway — anti-androgenic and anti-estrogenic — is why pumpkin seed oil outperformed saw palmetto in head-to-head comparisons (Vahlensieck et al., European Urology, 2015). One oil. Two mechanisms. Every link in the chain from DHT conversion to prostate growth to urethral compression to nocturia to sleep loss to testosterone suppression to erectile decline. Addressed at the root. Without the systemic hormone destruction that finasteride brings. But here's where it gets complicated, and this is what almost stopped me. Most pumpkin seed oil supplements on the market are essentially worthless for prostate repair. They use heat-extracted oil from generic seed stock with no standardization for phytosterol content. Commercial roasting destroys the delta-7-sterol fraction. Capsules filled with commodity oil might contain 50 mg of beta-sitosterol per serving. Maybe less. At those levels, your prostate tissue never accumulates enough of the compound to actually inhibit 5-alpha reductase. The clinical research used cold-pressed oil from Cucurbita pepo seeds with verified phytosterol content — minimum 1,000 mg of pumpkin seed oil per serving with the full beta-sitosterol and delta-7-sterol profile preserved through controlled extraction. The form matters. The dose matters. The seed variety matters. Most commercial supplements don't disclose their sterol content because they don't have any worth disclosing. I found one brand that actually met the clinical specifications. Everly Pumpkin Seed Oil Softgels. Cold-pressed Cucurbita pepo oil. Full phytosterol complex preserved. Three softgels daily delivers the clinical dose from the research. Third-party tested. I started taking three per day. Didn't tell my wife. Didn't set expectations. The first thing I noticed was the nights. Week two: down from three trips to two. Week four: one trip. Sometimes none. I'd wake up in the morning and realize I'd slept from 11 PM to 5:30 AM without my feet touching the floor once. That hadn't happened in two years. By week six, the morning erections came back. Not suddenly. Gradually. First maybe twice a week. Then more often than not. Then present almost every morning — the way they'd been in my forties before the prostate started growing without my knowledge. My wife noticed. She didn't say anything directly at first. But one Saturday morning she rolled toward me instead of away. That was enough. I rescanned myself at four months. Down from 42 cc to 36. Measurable, visible reduction in gland volume on the comparison images. I pulled both scans up side by side on my monitor. The same monitor where I'd measured Ray's prostate. Where I compare 40 to 50 scans a week. Where I'd spent 22 years measuring other men's prostates. This time the prostate getting smaller was mine. I called Ray. He'd been on the same protocol for three months. I'd shared it with him after I started seeing my own results. He told me he was down to one bathroom trip at night. "Doc, I moved back into our bedroom last month. First time in three years. My wife cried." I scheduled his follow-up ultrasound. Here's what 22 years of measuring prostates has taught me that most doctors will never tell you. Your PSA blood test and your prostate volume tell completely different stories. Your PSA test measures a protein floating in your bloodstream. Your ultrasound measures the actual size of the gland that's compressing your urethra, destroying your sleep, and quietly ending your sex life. A man can have a PSA under 4.0 and a prostate of 50 cc. Because PSA doesn't measure volume. It measures inflammation, infection, and cell turnover. Those aren't the same thing. Your GP manages a PSA number. He's probably never ordered a prostate ultrasound for volume measurement. He writes a prescription for tamsulosin, tells you to come back in six months, and sends you home. Your sleep gets worse. Your erections get weaker. Your relationship gets quieter. He doesn't connect any of those symptoms to the gland he never measured. I see all three. Every day. On a screen. Measured in cubic centimeters. And tamsulosin, which 84% of men with BPH are prescribed as first-line treatment, relaxes smooth muscle around a gland that's still growing every single day they take it. The growth continues. The volume increases. The symptoms progress. The medication dose increases. The urologist referral comes five years too late. If you're getting up more than once a night and your doctor says your PSA is "fine" — your blood test is measuring one thing. Your bladder is telling you something completely different. Your body already ran its own diagnostic. Every trip to the bathroom at 2 AM is your prostate announcing that it's still growing, still compressing, still winning. Or ignore the nights. Pay attention to the mornings instead. Morning erections are your vascular system's overnight test of smooth muscle function, testosterone levels, and sleep quality — all three of which are destroyed by the same enlarged prostate your tamsulosin isn't shrinking. If they're gone, the chain is already running. I see that confirmed on imaging every single day. If your PSA is "normal" and you haven't slept through the night in years, one of those tests is wrong. And after 22 years and 14,000 prostate scans, I can tell you which one I trust more. Dr. Caruso, MD, FACS Board-Certified Urologist, 22 years Prostate Imaging, BPH & Male Sexual Health P.S. The protocol Ray and I both use is Everly Pumpkin Seed Oil Softgels. Cold-pressed Cucurbita pepo oil, full phytosterol complex — beta-sitosterol and delta-7-sterols preserved through controlled extraction. Three softgels daily with food. Dual-action 5-alpha reductase inhibition and estrogen receptor modulation at the prostate tissue level without systemic hormone disruption. Third-party tested. Money-back guarantee. You can always go back to tamsulosin if nothing changes. But if your PSA is "normal" and your prostate volume tells a different story, something in your treatment plan is missing. 👉 https://shopeverly.shop/products/pumpkin-seed-oil-cold-pressed-softgels-3000mg-1-cc-select References: 1. McConnell, J.D., et al. (2003). The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. New England Journal of Medicine, 349(25), 2387-2398. 2. Roehrborn, C.G., et al. (2010). The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study. Journal of Urology, 183(3), 1087-1093. 3. Berges, R.R., et al. (1995). Randomised, placebo-controlled, double-blind clinical trial of β-sitosterol in patients with benign prostatic hyperplasia. The Lancet, 345(8964), 1529-1532. 4. Berges, R.R., et al. (2000). Treatment of symptomatic benign prostatic hyperplasia with β-sitosterol: an 18-month follow-up. BJU International, 85(7), 842-846. 5. Vahlensieck, W., et al. (2015). Effects of pumpkin seed in men with lower urinary tract symptoms due to benign prostatic hyperplasia in the one-year, randomized, placebo-controlled GRANU study. Urologia Internationalis, 94(3), 286-295. 6. Hong, H., et al. (2009). Effects of pumpkin seed oil and saw palmetto oil in Korean men with symptomatic benign prostatic hyperplasia. Nutrition Research and Practice, 3(4), 323-327. 7. Coyne, K.S., et al. (2009). The impact of nocturia on health-related quality of life and health resource utilization: Results from the UrEpik study. BJU International, 103(7), 955-961. 8. Rosen, R., et al. (2003). Lower urinary tract symptoms and male sexual dysfunction: The Multinational Survey of the Aging Male (MSAM-7). European Urology, 44(6), 637-649.